Brain transcriptomic and proteomic analyses in an in vivo AD model further elucidate the role of the sigma-2 receptor modulator CT1812 in Alzheimer’s disease

Elayta (CT1812) - Cognition Therap

https://alz.confex.com/alz/2023/meetingapp.cgi/Paper/83209

Valentina Di Caro, PhD1; Eunah Cho, PhD1; Jill Caldwell1; Kiran Pandey, PhD2; Duc M. Duong, PhD3; Nicholas T Seyfried, PhD3; Anthony O Caggiano, MD, PhD4; Mary E Hamby, PhD1

Jul 7, 2023